Cancers (Jan 2023)

Outcomes of Surgical Treatment for Extradural Benign Primary Spinal Tumors in Patients Younger than 25 Years: An Ambispective International Multicenter Study

  • Alexander C. Disch,
  • Stefano Boriani,
  • Aron Lazary,
  • Laurence D. Rhines,
  • Alessandro Luzzati,
  • Ziya L. Gokaslan,
  • Charles G. Fisher,
  • Michael G. Fehlings,
  • Michelle J. Clarke,
  • Dean Chou,
  • Nicole M. Germscheid,
  • Klaus-Dieter Schaser,
  • Jeremy J. Reynolds,
  • The AO Spine Knowledge Forum Tumor

DOI
https://doi.org/10.3390/cancers15030650
Journal volume & issue
Vol. 15, no. 3
p. 650

Abstract

Read online

Extradural primary spinal tumors were retrospectively analyzed from a prospective database of 1495 cases. All subjects with benign primary tumors under the age of 25 years, who were enrolled between 1990 and 2012 (Median FU was 2.4 years), were identified. Patient- and case-related characteristics were collected and statistically analyzed. Results: 161 patients (66f;95m; age 17.0 ± 4.7 years at time of diagnosis) were identified. The most common tumors were osteoblastomas n = 53 (32.9%), osteoid osteomas n = 45 (28.0%), and aneurysmal bone cysts n = 32 (19.9%). The tumor grade, according to the Enneking Classification S1/S2/S3, was 14/73/74 (8.7/45.3/46.0%), respectively. Tumor-related pain was present in 156 (96.9%) patients. Diagnosis was achieved by biopsies in 2/3 of the cases. Spinal fixation was used in >50% of the cases. Resection was Enneking appropriate in n = 100 (62.1%) of cases. Local recurrence occurred in 21 (13.1%) patients. Two patients died within a 10-year follow-up period. Conclusion: This is one of the largest international multicenter cohorts of young patients surgically treated for benign spinal tumors. The heterogenic young patient cohort presented at a mid-term follow-up without a correlation between the grade of aggressiveness in resection and local recurrence rates. Further prospective data are required to identify prognostic factors that determine oncological and functional outcomes for young patients suffering from these rare tumors.

Keywords